{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:49:12Z","timestamp":1772722152841,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1093\/europace\/eup068","type":"journal-article","created":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T20:46:10Z","timestamp":1239309970000},"page":"716-726","source":"Crossref","is-referenced-by-count":67,"title":["Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population"],"prefix":"10.1093","volume":"11","author":[{"given":"Martin R.","family":"Cowie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ferko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"de Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Verboven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,4,9]]},"reference":[{"key":"key\n\t\t\t\t20170517034932_EUP068C1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"27","author":"Zipes","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170517034932_EUP068C2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-142-8-200504190-00007","article-title":"Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II","volume":"142","author":"Al Khatib","year":"2005","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10270","article-title":"A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and the modelling of cost-effectiveness and cost-utility for these groups in a UK context","volume":"10","author":"Buxton","year":"2006","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20170517034932_EUP068C5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2143\/AC.55.4.2005746","article-title":"Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS economic analysis group. West of Scotland Coronary Prevention Study","volume":"55","author":"Caro","year":"2000","journal-title":"Acta Cardiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMsa051989","article-title":"Cost-effectiveness of implantable cardioverter-defibrillators","volume":"353","author":"Sanders","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C7","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","article-title":"The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"47","author":"Zwanziger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C8","article-title":"De implanteerbare defribrillator: een health technology assessment (HTA)","author":"Van Brabandt","year":"2007"},{"key":"key\n\t\t\t\t20170517034932_EUP068C9","unstructured":"Life Tables for WHO Member States http:\/\/www.who.int\/whosis\/database\/life_tables\/life_tables.cfm"},{"key":"key\n\t\t\t\t20170517034932_EUP068C10","article-title":"Guidelines for pharmacoeconomic evaluations in Belgium. Health technology assessment (HTA)","author":"Cleemput","year":"2008"},{"key":"key\n\t\t\t\t20170517034932_EUP068C11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C13","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2014AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170517034932_EUP068C16","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C17","volume-title":"Version 4.2 for Windows","author":"Review Manager (RevMan) [computer program]","year":"2003"},{"key":"key\n\t\t\t\t20170517034932_EUP068C18","author":"Convention entre le comit\u00e9 de l'assurance soins de sant\u00e9 de l'Institut National Assurance Maladie-Invalidit\u00e9 et l'\u00e9tablissement hospitalier"},{"key":"key\n\t\t\t\t20170517034932_EUP068C19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1540-8167.2003.01554.x","article-title":"Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial","volume":"14","author":"Klein","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C20","article-title":"Economic evaluation study of implantable cardioverter defibrillators","author":"Scuffham","year":"2003"},{"key":"key\n\t\t\t\t20170517034932_EUP068C21","unstructured":"Medtronic CRDM Product Performance Report GEM II VR (single chamber) www.crdmppr.medtronic.com"},{"key":"key\n\t\t\t\t20170517034932_EUP068C22","unstructured":"INAMI http:\/\/tct.fgov.be\/etct\/"},{"key":"key\n\t\t\t\t20170517034932_EUP068C23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1524-4733.1998.11004919.x","article-title":"Evaluation of the costs of heart failure in Belgium","volume":"1","author":"Annemans","year":"1998","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20170517034932_EUP068C24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170517034932_EUP068C25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.mlr.0000257142.12600.c1","article-title":"Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT-II","volume":"45","author":"Noyes","year":"2007","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170517034932_EUP068C26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","article-title":"Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator","volume":"144","author":"Owens","year":"2002","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170517034932_EUP068C27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1192\/bjp.187.2.106","article-title":"A guide to cost-effectiveness acceptability curves","volume":"187","author":"Fenwick","year":"2005","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t20170517034932_EUP068C28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"key\n\t\t\t\t20170517034932_EUP068C29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1539-6924.1995.tb00330.x","article-title":"Five-hundred life-saving interventions and their cost-effectiveness","volume":"15","author":"Tengs","year":"1995","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170517034932_EUP068C30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.2000.2371","article-title":"Cost-effectiveness of implantable cardioverter-defibrillators","volume":"22","author":"Boriani","year":"2001","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170517034932_EUP068C31","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMsb050564","article-title":"Medicare and cost-effectiveness analysis","volume":"353","author":"Neumann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170517034932_EUP068C32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/eurheartj\/sum062","article-title":"Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association","volume":"9","author":"Ector","year":"2007","journal-title":"Eur Heart J Suppl"},{"key":"key\n\t\t\t\t20170517034932_EUP068C33","article-title":"Product performance report: cardiac rhythm management","author":"St Jude Medical","year":"2007"},{"key":"key\n\t\t\t\t20170517034932_EUP068C34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1460-9592.2003.00153.x","article-title":"Variability in implantable cardioverter defibrillator pulse generator longevity between manufacturers","volume":"26","author":"Ellinor","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1540-8159.2006.00497.x","article-title":"Pacemaker longevity: are we getting what we are promised?","volume":"29","author":"Senaratne","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20170517034932_EUP068C36","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0021-9150(97)00321-3","article-title":"Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model","volume":"137","author":"Muls","year":"1998","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170517034932_EUP068C37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1460-9592.2001.00082.x","article-title":"Feasibility and initial results of an internet-based pacemaker and ICD pulse generator and lead registry","volume":"24","author":"Hauser","year":"2001","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/11\/6\/716\/17157543\/eup068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T21:58:50Z","timestamp":1503439130000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article-lookup\/doi\/10.1093\/europace\/eup068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,9]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,4,9]]},"published-print":{"date-parts":[[2009,6]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eup068","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4,9]]}}}